Cargando…
Precision Medicine for Rheumatoid Arthritis: The Right Drug for the Right Patient—Companion Diagnostics
Despite the growing number of biologic and JAK inhibitor therapeutic agents available to treat various systemic autoimmune illnesses, the lack of a validated companion diagnostic (CDx) to accurately predict drug responsiveness for an individual results in many patients being treated for years with e...
Autores principales: | Meehan, Richard Thomas, Amigues, Isabelle Anne, Knight, Vijaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391624/ https://www.ncbi.nlm.nih.gov/pubmed/34441297 http://dx.doi.org/10.3390/diagnostics11081362 |
Ejemplares similares
-
Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?
por: Romão, Vasco C., et al.
Publicado: (2017) -
Emerging biomedical imaging-based companion diagnostics for precision medicine
por: Liao, Shiyi, et al.
Publicado: (2023) -
Current Perspectives On Emerging Biomarkers For Rheumatoid Arthritis-Associated Interstitial Lung Disease
por: Amigues, Isabelle, et al.
Publicado: (2019) -
The “rights” of precision drug development for Alzheimer’s disease
por: Cummings, Jeffrey, et al.
Publicado: (2019) -
Lyme disease: the promise of Big Data, companion diagnostics and precision medicine
por: Stricker, Raphael B, et al.
Publicado: (2016)